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The efficiency of transplacental transfer of measles specific
antibody was assessed in relation to placental malaria.
Infection at delivery was associated with a 30% decrease in
expected cord measles antibody titres. Uninfected women
who received anti-malarial drugs during pregnancy trans-
mitted 30% more antibody than those who received no
antimalarial drugs.
M
easles kills one million children each year, although a
vaccine has been a component of the WHO Expanded
Programme of Immunisation since 1985. The trans-
placental transfer of measles immunoglobulin G (IgG) from
mother to fetus is a key component of infant immunity and
partially determines the successful response to vaccination.1
We previously reported that 10% of babies born to mothers
with heavy Plasmodium falciparum infections failed to acquire
protective levels of tetanus antibody, despite adequate
maternal levels.2 However, conflicting data on the effect of
placental malaria on fetal acquisition of maternal antibodies
were recently reported.3 Malaria is known to disrupt the
placental architecture, leading to a massive infiltration of
monocytes, thickening of the basement membranes, and
extensive fibrin deposition in the materno–fetal transfer
membrane (syncytiotrophoblast).4 Placental malaria is a
leading cause of low birthweight in Africa, especially in
primigravidae, who lose previously acquired immunity and
become particularly susceptible to parasitisation.4 We
assessed the efficiency of transplacental transfer of measles
antibody in 104 HIV negative mother-infant pairs living in
Kumasi, Ghana, in relation to placental malaria and exposure
to antimalarial drugs during pregnancy.
METHODS
Consenting women who delivered vaginally at the Komfo
Anokye Teaching Hospital, Kumasi, Ghana were enrolled
between April and June 2003. Demographic and retrospective
antenatal data were obtained by questionnaire and from the
antenatal health card. Babies and placentae were weighed to
the nearest 50 g. Hypertensive women and those delivering
stillborn infants, multiple births, or infants with congenital
abnormities were excluded.
Maternal and cord blood samples (10 ml) were obtained by
venepuncture at delivery. Placental biopsies were obtained
from an off-centre position and stored in 10% formaldehyde
in phosphate buffer. Paraffin embedded sections were
stained with haematoxylin-eosin and examined by light
microscopy under polarised light. Placental malaria infection
was defined by the presence of parasites and malaria pigment
into non-infected, active infection, and past infection.4 Total
IgG was assayed by laser nephelometry (Beckmann) and
measles specific antibodies were measured by commercial
enzyme linked immunoassay (ELISA). Anonymous HIV
testing of maternal samples was undertaken by non-
quantitative ELISA, and three HIV positive women were
excluded. Maternal and cord blood haemoglobin was
measured on HemocueH. Ethical approval was obtained from
both participating institutions before fieldwork was under-
taken.
Log10 transformed cord measles antibody titres were
regressed on log10 transformed maternal titres, and placental
histological classification fitted to the linear model.2 3 The
influence of key potential confounding variables (gestational
age, birthweight, and maternal total IgG concentration) was
assessed in a multivariate model. Ratios of cord:maternal
antibody titres were calculated and then log10 transformed,
generating geometric mean transfer ratios as a measure of
transfer efficiency.3
RESULTS
Placental malaria infection was detected in 33 of 104 subjects
(31.7%), active infection in 18 of 104 (17.3%), past infection
in 15 of 104 (14.4%), and no infection in 71 of 104 (68.3%).
Placental malaria prevalence among primiparae was 50% and
among multiparae 20.3% (odds ratio = 3.92 (95% confidence
interval (CI), 1.65 to 9.35)). There were no cases of cord
parasitaemia. During pregnancy, 51.5% of subjects took
antimalarial drugs for prophylaxis or for empirical malaria
treatment. There were no significant differences in antenatal
attendance, maternal age, parity, nutritional status (indi-
cated by mid-upper arm circumference), and placental
malaria prevalence at delivery between subjects who did
and did not use antimalarial agents.
Placental infection was associated with reduced maternal
haemoglobin (104 v 117 g/l; p,0.001), lower birthweight
(2.85 v 3.08 kg; p = 0.019), and increased geometric mean
maternal total IgG (50.4 v 28.9 g/l; p,0.001). Placental
infection was not significantly associated with geometric
mean maternal measles antibody titres (65.8 v 50.4 ELISA
units/l). The relation between cord and maternal antibody
titres and placental malaria infection was defined under
linear regression (R2 = 0.46; p,0.001) and is illustrated in
fig 1. Placental histological classification slightly improved
the model (R2 = 0.49; p,0.001) in multivariate analysis.
Other confounding variables were insignificant and were
excluded. The expected cord titre in active placental malaria
infection was 70.5% (95% CI, 52.0% to 95.5%) of that
expected with no placental infection, and in past infection,
68.7% (49.5% to 95.5%). The relation between antimalarial
treatment and the transformed cord:maternal measles anti-
body transfer ratio is illustrated in fig 2. Among non-infected
mothers, those who received antimalarial drugs during
pregnancy transferred significantly more measles antibody
than those who did not (geometric mean transfer ratios: 1.33
v 0.98 respectively; p = 0.046).
DISCUSSION
Placental malaria was associated with impaired transplacen-
tal transfer of measles antibody in this study. Antenatal
antimalarial drug exposure was associated with improved
transfer in women uninfected at delivery. Such women were
likely to have been infected earlier in pregnancy but cleared
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the parasites more effectively, limiting placental pathology
and improving the transfer capacity of the syncytiotropho-
blast. Antimalarial drug exposure may have represented
demographic confounding but no evidence for this was
detected in the variables examined, and exposure was
irrelevant in women infected at delivery. Potential interac-
tions between placental malaria and HIV co-infection3 were
avoided in this HIV seronegative sample.
Reduced concentration of measles antibody at birth is
critical in determining early susceptibility and severity of
measles infection in infants, as well as the timing of effective
measles vaccination. In Malawi between 1996 and 1998, 51%
of infants with measles were less than 9 months of age and
17% less than 6 months.5 Improved malaria control in
pregnancy has substantial benefits for the mother and the
baby, which may include a reduced risk of measles in early
infancy. Studies of infant measles susceptibility in relation to
placental malaria and maternal antibody transfer are
warranted.
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Figure 1 Scatterplot of log10 transformed cord/maternal measles
antibody titres. Regression lines are fitted according to placental
infection. Broken line and crosses: infected placentas; continuous line
and circles, non-infected placentas.
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Figure 2 Box plot of cord:maternal measles antibody titre according to
placental malaria infection status and history of antimalarial drug
treatment during pregnancy.
508 Owens, Harper, Amuasi, et al
www.archdischild.com
 group.bmj.com on March 22, 2011 - Published by adc.bmj.comDownloaded from 
doi: 10.1136/adc.2005.085274
 2006 91: 507-508Arch Dis Child
 
S Owens, G Harper, J Amuasi, et al.
 
measles
Placental malaria and immunity to infant
 http://adc.bmj.com/content/91/6/507.full.html
Updated information and services can be found at: 
These include:
References
 http://adc.bmj.com/content/91/6/507.full.html#ref-list-1
This article cites 4 articles, 1 of which can be accessed free at:
service
Email alerting
box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic
 (27615 articles)Reproductive medicine   
 (15841 articles)Pregnancy   
 (215 articles)Tropical medicine (infectious diseases)   
 (152 articles)Travel medicine   
 (2453 articles)Drugs: infectious diseases   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on March 22, 2011 - Published by adc.bmj.comDownloaded from 
